Nexstim Receives an NBT® System Order from Alamo Neurosurgical Institute
25 oct. 2022 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 25 October 2022 at 9 AM (EEST) Nexstim Receives an NBT® System Order from Alamo Neurosurgical Institute Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces...
Nexstim NBS 5+ System Continues to Generate Interest in the US
06 oct. 2022 05h00 HE
|
Nexstim Oyj
Press release, Helsinki, 6 October 2022 at 12 PM (EEST) Nexstim NBS 5+ System Continues to Generate Interest in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Drs....
Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital
02 juin 2022 03h00 HE
|
Nexstim Oyj
Press release, Helsinki, 2 June 2022 at 10 AM (EEST) Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") today...
Global Deep Brain Stimulation Market Growth Opportunities Report 2022: Top 3 Growth Opportunities in the Space for Medical Device and Technology Companies to Target
31 mai 2022 06h53 HE
|
Research and Markets
Dublin, May 31, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The study assesses the current market...
Seattle Police Department Partners With Fisher Wallace to Improve Officer Wellness
07 avr. 2022 10h00 HE
|
Fisher Wallace
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Today, the Seattle Police Department (SPD) has announced a strategic partnership with Fisher Wallace, the market leader in prescription wearable...
Nexstim Receives an NBS 5+ System Order from a US Customer
06 avr. 2022 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 6 April 2022 at 9 AM (EEST) Nexstim Receives an NBS 5+ System Order from a US Customer Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces having received...
Fisher Wallace Completes 2.5 Million Dollar Investment From SHUFL Capital
29 mars 2022 07h30 HE
|
Fisher Wallace Laboratories, Inc.
NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Fisher Wallace Laboratories, the market leader in prescription wearable technology for the treatment of neuropsychiatric disorders, announces today the...
Nexstim Receives a System Upgrade Order from a Customer in Finland
16 févr. 2022 02h30 HE
|
Nexstim Oyj
Press release, Helsinki, 16 February 2022 at 9:30 AM (EET) Nexstim Receives a System Upgrade Order from a Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has received...
Actipulse Neuroscience Joins Y Combinator
25 janv. 2022 08h30 HE
|
Actipulse Neuroscience
BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Actipulse Neuroscience, a Boston and Mexico-City-based startup pioneer in Non-Invasive Brain Stimulation therapeutics, today announces its participation in...
Worldwide Deep Brain Stimulation Devices Industry to 2026 - Key Drivers and Challenges
24 janv. 2022 04h48 HE
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation (DBS) Devices Market, By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type...